Abstract:Objective To explore the effects of 1,25-(OH) 2-D 3 in combined with DBMC to induce tolerance on heterotopic rat cardiac allografts.Methods After the establishment of a stable rat cervical heterotopic heart transplantation model, inbred male Wistar rat hearts were transplanted to male SD rats. The experimental rats were divided into the following groups: Group A served as experimental control group, group B receiving 1,25-(OH) 2-D 3 5000 ng/kg, group C being treated with 1×10 8 DBMC, group D being treated with 1×10 8 DBMC in combined with 1,25-(OH) 2-D 3 5000 ng/kg and group E being treated with CsA 10?mg/kg. The survival time of donor hearts was observed, meanwhile, the donor specific mixed lymphocyte reaction (MLR) and concentrations of TNF-alpha and ICAM-1 in grafts were measured. HE staining inspected all specimens of heart grafts.Results The mean graft survival time (days) in the groups A, B, C, D and E group was 7.2 ± 1.6 , 10.6 ± 2.3 , 12.4 ± 2.5 , 68.3 ± 9.9 and 17.5 ± 4.4 , respectively. The results showed there were significant differences in graft survival time between the group D and the other groups ( P 0.05 ). Cytokine mRNA analysis in the grafts 8 days after operation revealed a clear suppression of TNF-alpha and ICAM-1 in the group D rats. The proliferation of anergic cells in the group C, group D and group E in the MLR were strongly inhibited on the day 7 after transplantation. The typical features of acute rejection were observed by pathological studies in the specimens of all groups. There were not any severe complications among all receptors.Conclusion 1,25-(OH) 2-D 3 in combined with DBMC has a synergistic effect and can achieve the best effects on the inducement of immunological tolerance and the improvement of graft survival.

Combined Use of Vitamin D-derived Drug and DBMC to Induce Tolerance on Heterotopic Rat Cardiac Allograft